CORE

🇺🇦   make metadata, not war

    4 research outputs found

    Phase I study of epigenetic priming using azacitidine prior to neoadjuvant chemotherapy in patients with resectable esophageal and gastric adenocarcinoma.

    Author
    Publication venue
    'American Society of Clinical Oncology (ASCO)'
    Publication date
    Field of study
    No full text
    Crossref

    A multicenter phase I study of intravenous administration of reolysin in combination with irinotecan/fluorouracil/leucovorin (FOLFIRI) in patients (pts) with oxaliplatin-refractory/intolerant KRAS-

    Author
    Publication venue
    'American Society of Clinical Oncology (ASCO)'
    Publication date
    Field of study
    No full text
    Crossref

    Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response

    Author
    Publication venue
    'American Association for Cancer Research (AACR)'
    Publication date
    Field of study
    No full text
    Crossref

    The Historian’s Silences: What Livy Did Not Know—Or Chose Not to Tell

    Author
    Publication venue
    'Walter de Gruyter GmbH'
    Publication date
    Field of study
    No full text
    Crossref
    corecore